Patents by Inventor Manuel Vangelisti

Manuel Vangelisti has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Live-attenuated yellow fever virus strain adapted to grow on Vero cells and vaccine composition comprising the same
    Patent number: 11471521
    Abstract: The invention relates to a live-attenuated yellow fever virus strain adapted to grow on Vero cells from a parent yellow fever virus 17D substrain that is not adapted to grow on Vero cells, wherein said live-attenuated yellow fever virus strain is less neurovirulent than said parent yellow fever virus 17D substrain.
    Type: Grant
    Filed: April 2, 2019
    Date of Patent: October 18, 2022
    Assignee: Sanofi Pasteur
    Inventors: Manuel Vangelisti, Nathalie Mantel, Yves Girerd-Chambaz, Fabienne Piras
  • Live-attenuated yellow fever virus strain adapted to grow on Vero cells and vaccine composition comprising the same
    Patent number: 11452772
    Abstract: The invention relates to a live-attenuated yellow fever virus strain adapted to grow on Vero cells from a parent yellow fever virus 17D substrain that is not adapted to grow on Vero cells, wherein said live-attenuated yellow fever virus strain is less neurovirulent than said parent yellow fever virus 17D substrain.
    Type: Grant
    Filed: November 5, 2021
    Date of Patent: September 27, 2022
    Assignee: Sanofi Pasteur
    Inventors: Manuel Vangelisti, Nathalie Mantel, Yves Girerd-Chambaz, Fabienne Piras
  • Live-Attenuated Yellow Fever Virus Strain Adapted to Grow on Vero Cells and Vaccine Composition Comprising the Same
    Publication number: 20220047692
    Abstract: The invention relates to a live-attenuated yellow fever virus strain adapted to grow on Vero cells from a parent yellow fever virus 17D substrain that is not adapted to grow on Vero cells, wherein said live-attenuated yellow fever virus strain is less neurovirulent than said parent yellow fever virus 17D substrain.
    Type: Application
    Filed: November 5, 2021
    Publication date: February 17, 2022
    Inventors: Manuel Vangelisti, Nathalie Mantel, Yves Girerd-Chambaz, Fabienne Piras
  • Live-Attenuated Yellow Fever Virus Strain Adapted to Grow on Vero Cells and Vaccine Composition Comprising the Same
    Publication number: 20210154289
    Abstract: The invention relates to a live-attenuated yellow fever virus strain adapted to grow on Vero cells from a parent yellow fever virus 17D substrain that is not adapted to grow on Vero cells, wherein said live-attenuated yellow fever virus strain is less neurovirulent than said parent yellow fever virus 17D substrain.
    Type: Application
    Filed: April 2, 2019
    Publication date: May 27, 2021
    Inventors: Manuel Vangelisti, Nathalie Mantel, Yves Girerd-Chambaz, Fabienne Piras
  • Process for the preparation of 2-aminomethylpyridine derivative
    Patent number: 7456290
    Abstract: Process for the preparation of 2-aminomethylpyridine derivative of general formula (I) or a salt thereof, formula (I) in which:—n represents 0, 1, 2 or 3,—X is halogen atom,—each Y may be the same or different and may be a halogen atom, a halogenoalkyl, an alkoxycarbonyl or an alkylsulphonyl.
    Type: Grant
    Filed: November 18, 2003
    Date of Patent: November 25, 2008
    Assignee: Bayer Cropscience S.A.
    Inventor: Manuel Vangelisti
  • Process for the preparation of 2-aminomethylpyridine derivative
    Patent number: 7232911
    Abstract: Process for the preparation of 2-aminomethylpyridine derivative of general formula (I), in which: n represents 0, 1, 2 or 3; X is halogen atom; Y may be the same or different and may be a halogen atom, a halogenoalkyl, a alkoxycarbonyl or a alkylsulphonyl
    Type: Grant
    Filed: November 18, 2003
    Date of Patent: June 19, 2007
    Assignee: Bayer Cropscience S.A.
    Inventors: Manuel Vangelisti, Mehul Amin, Robert Pannell
  • Process for the preparation of 2-aminomethylpyridine derivative
    Publication number: 20060100441
    Abstract: Process for the preparation of 2-aminomethylpyridine derivative of general formula (I), in which: n represents 0, 1, 2 or 3; X is halogen atom; Y may be the same or different and may be a halogen atom, a halogenoalkyl, a alkoxycarbonyl or a alkylsulphonyl.
    Type: Application
    Filed: November 18, 2003
    Publication date: May 11, 2006
    Inventors: Manuel Vangelisti, Mehul Amin
  • Novel process for the preparation of 2-aminomethylpyridine derivative
    Publication number: 20060004206
    Abstract: Process for the preparation of 2-aminomethylpyridine derivative of general formula (I) or a salt thereof, formula (I) in which:-n represents 0, 1, 2 or 3,-X is halogen atom,-each Y may be the same or different and may be a halogen atom, a halogenoalkyl, an alkoxycarbonyl or an alkylsulphonyl.
    Type: Application
    Filed: November 18, 2003
    Publication date: January 5, 2006
    Applicant: BAYER CROPSCIENCE S.A.
    Inventor: Manuel Vangelisti
  • Processes for preparing pesticidal intermediates
    Patent number: 6410737
    Abstract: Compounds of formula (I) are prepared by hydrogenolysis of a compound of formula (II): where R1 is haloalkyl, haloalkoxy or −SF5; W is N or CR3; and R2 and R3 are H or Cl. The compounds of formula (I) can be used as intermediates in the preparation of pesticidally active arylpyrazole compounds.
    Type: Grant
    Filed: January 4, 2002
    Date of Patent: June 25, 2002
    Assignee: Aventis CropScience, S.A.
    Inventors: Jean-Erick Ancel, Gilles Perrin-Janet, Manuel Vangelisti, Pierre Versproumy